SEARCH NEWS & VIEWS


New Chemistry Method Simplifies Late-Stage Modification of Drug Compounds
To Forget or to Remember? Memory Depends on Subtle Brain Signals, Scientists Find
Good Cells Gone Bad
New Findings to Help HIV Scientists Establish ‘Template’ for Potent Antibodies
The Scripps Research Institute Welcomes Renowned Data Scientist Amalio Telenti
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US

Of Note


CONNECT Honors Richard Lerner for Contributions to Life Science Innovation

Richard A. Lerner, M.D., Lita Annenberg Hazen Professor of Immunochemistry at The Scripps Research Institute (TSRI) has been awarded the CONNECT Duane Roth Distinguished Contribution Award for Life Science Innovation.

CONNECT is a premier innovation company accelerator in San Diego that creates and scales great companies in the technology and life sciences sectors. The company’s Most Innovative New Product Awards ceremony “recognizes and lauds stars of innovation and their latest groundbreaking products.”

Lerner was president of TSRI for 20 years. His research focuses on protein engineering techniques and the use of catalytic antibodies as therapeutic tools. His work has resulted in two drugs: Humira®, which treats inflammatory diseases such as rheumatoid arthritis; and Benlysta®, which treats the most common form of lupus. In a study out this year, Lerner’s team announced a way to tether an anti-HIV antibody to cells, making cells resistant to HIV.

Learn more about Lerner’s research: http://www.scripps.edu/research/faculty/lerner


Graduate Student Murat Kilinc Receives Autism Speaks Fellowship

Murat Kilinc, a graduate student in the Rumbaugh Lab on the Florida campus of The Scripps Research Institute (TSRI), has been named a 2017 Weatherstone Predoctoral Fellow by Autism Speaks.

The highly competitive Weatherstone program supports ground-breaking studies conducted under the mentorship of leading scientists—and serves as a launching pad for the careers of promising autism researchers. With this new $64,000 grant, Kilinc will be working to determine how different isoforms of the protein Syngap1 regulate dendritic development and synapse physiology in neurons. This research could lead to new biological targets for autism treatments.

According to Autism Speaks, “This research has the potential to advance our understanding of autism and intellectual disability at the molecular and brain systems level.”





Send comments to: press[at]scripps.edu

connect
Richard Bregman of Bank of America presented the award on behalf of CONNECT to TSRI Professor Richard Lerner, M.D. (Photo by Frank Rogozienski, CONNECT)